Stockholm, Sweden
Director Clinical Development at Intervacc AB
Biotechnology
Education
Karolinska institutet 1992 — 1998
PhD, Clinical Neuroscience
Stockholm University 1989 — 1992
B.Sc., Molecular Biology
Experience
Intervacc AB August 2013 - Present
Landstinget i Östergötland January 2013 - June 2013
NeuroNova October 2003 - December 2012
NeuroNova AB August 2001 - September 2003
University of Cambridge August 1999 - July 2001
King's College London September 1998 - July 1999
Karolinska Institutet, Dep. Clin. Neurosci., Psychiatry Sect. May 1993 - September 1998
Karolinska Institutet 1991 - 1998
Karolinska Insitutet, Lab. Mol. Neurbiology December 1991 - May 1993
Skills
Drug Development, Immunohistochemistry, Assay Development, Medical Devices, ISO 13485, Cell, Clinical Research, GMP, Clinical Development, Biotechnology, Animal Models, R&D, Cell Culture, Cell Biology, Neuroscience, Molecular Biology, Drug Discovery, Neuropharmacology, Biostatistics, GLP, In Vitro, Science, Biomarkers, Stem Cells, Protein Expression, Signal Transduction, Lifesciences, In Vivo, Translational Medicine, Bioinformatics, Immunology, Clinical Trials, Pharmacology, Phase I, ELISA, Project Management, Medical Writing, Antibodies, DNA, Pharmaceutical Industry, GCP, Therapists, Staff Management, CRO, Vaccines, Biochemistry, Research